Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India

Aim: The present study was conducted to evaluate the incidence and characteristics of infections in patients of systemic lupus erythematosus (SLE) and determine the risk factors for infection. Materials and Methods: This is a prospective, observational study carried out at a single-center, tertiary...

Full description

Saved in:
Bibliographic Details
Main Authors: Ankan Jha, Tridip Das, Sunilkumar Rajmani Singh, Jyotsna Oak
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=1;spage=4;epage=9;aulast=Jha
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544422100729856
author Ankan Jha
Tridip Das
Sunilkumar Rajmani Singh
Jyotsna Oak
author_facet Ankan Jha
Tridip Das
Sunilkumar Rajmani Singh
Jyotsna Oak
author_sort Ankan Jha
collection DOAJ
description Aim: The present study was conducted to evaluate the incidence and characteristics of infections in patients of systemic lupus erythematosus (SLE) and determine the risk factors for infection. Materials and Methods: This is a prospective, observational study carried out at a single-center, tertiary care hospital. The study included all adult SLE patients diagnosed as per the revised American College of Rheumatology (ACR) criteria from January 2015 to October 2019. Episodes of infection and pathogens isolated were recorded. Results: A total of 100 patients with SLE were evaluated (94 females and 6 males). Forty-seven (47%) patients suffered from 54 episodes of infection. Urinary tract infections were most common (31.48%), followed by skin and mucous membrane (27.78%). Escherichia coli (E. coli) was the most common organism isolated in 9 (16.8%) cases. Tuberculosis was seen in 6 (11.1%) patients. Forty-three (79.6%) patients had a SLE disease activity index score of more than 5 at the time of infection. Significant risk factors for infection included use of prednisolone, prednisolone dose higher than 10 mg, use of cyclophosphamide within the preceding 3 months of infections, use of other immunosuppressive agents, and leukopenia. Renal lupus and presence of comorbidities did not have a significant association with occurrence of infections. The relative risk of infections in SLE patients was 4.7 compared to non SLE controls. Conclusion: Patients of SLE are at increased risk for various infections. Management of SLE needs vigilance for infection and judicious use of immunosuppressive drugs.
format Article
id doaj-art-9f25f0dc18d8465f98ebeab90011edb5
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2022-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-9f25f0dc18d8465f98ebeab90011edb52025-02-03T10:23:12ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012022-01-011714910.4103/injr.injr_65_21Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western IndiaAnkan JhaTridip DasSunilkumar Rajmani SinghJyotsna OakAim: The present study was conducted to evaluate the incidence and characteristics of infections in patients of systemic lupus erythematosus (SLE) and determine the risk factors for infection. Materials and Methods: This is a prospective, observational study carried out at a single-center, tertiary care hospital. The study included all adult SLE patients diagnosed as per the revised American College of Rheumatology (ACR) criteria from January 2015 to October 2019. Episodes of infection and pathogens isolated were recorded. Results: A total of 100 patients with SLE were evaluated (94 females and 6 males). Forty-seven (47%) patients suffered from 54 episodes of infection. Urinary tract infections were most common (31.48%), followed by skin and mucous membrane (27.78%). Escherichia coli (E. coli) was the most common organism isolated in 9 (16.8%) cases. Tuberculosis was seen in 6 (11.1%) patients. Forty-three (79.6%) patients had a SLE disease activity index score of more than 5 at the time of infection. Significant risk factors for infection included use of prednisolone, prednisolone dose higher than 10 mg, use of cyclophosphamide within the preceding 3 months of infections, use of other immunosuppressive agents, and leukopenia. Renal lupus and presence of comorbidities did not have a significant association with occurrence of infections. The relative risk of infections in SLE patients was 4.7 compared to non SLE controls. Conclusion: Patients of SLE are at increased risk for various infections. Management of SLE needs vigilance for infection and judicious use of immunosuppressive drugs.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=1;spage=4;epage=9;aulast=Jhacyclophosphamideinfectionsprednisolonesystemic lupus erythematosustuberculosis
spellingShingle Ankan Jha
Tridip Das
Sunilkumar Rajmani Singh
Jyotsna Oak
Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
Indian Journal of Rheumatology
cyclophosphamide
infections
prednisolone
systemic lupus erythematosus
tuberculosis
title Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
title_full Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
title_fullStr Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
title_full_unstemmed Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
title_short Infections in systemic lupus erythematosus: A study of incidence and risk factors in 100 patients from western India
title_sort infections in systemic lupus erythematosus a study of incidence and risk factors in 100 patients from western india
topic cyclophosphamide
infections
prednisolone
systemic lupus erythematosus
tuberculosis
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=1;spage=4;epage=9;aulast=Jha
work_keys_str_mv AT ankanjha infectionsinsystemiclupuserythematosusastudyofincidenceandriskfactorsin100patientsfromwesternindia
AT tridipdas infectionsinsystemiclupuserythematosusastudyofincidenceandriskfactorsin100patientsfromwesternindia
AT sunilkumarrajmanisingh infectionsinsystemiclupuserythematosusastudyofincidenceandriskfactorsin100patientsfromwesternindia
AT jyotsnaoak infectionsinsystemiclupuserythematosusastudyofincidenceandriskfactorsin100patientsfromwesternindia